Dalfopristin and quinupristin come as an intravenous (IV) infusion, which means it’s injected into a vein. Here’s how to use it:

• Administration: This medication is usually administered in a hospital or healthcare setting by a trained healthcare provider. It is given through an IV infusion, which may take 1 hour or more, depending on the prescribed protocol.
• Infusion Schedule: The typical schedule for the drug is every 8 to 12 hours, and the dosage may vary depending on the type and severity of the infection.
• Monitor for Reactions: While receiving this medication, your healthcare provider will monitor you for any side effects, such as allergic reactions or issues with your liver or kidneys.

You should not try to administer this medication on your own. It is important to follow your healthcare provider’s instructions carefully.

Dalfopristin and quinupristin work together to stop bacteria from making the proteins they need to grow and multiply. Here’s how they work:

• Dalfopristin: This antibiotic binds to bacterial ribosomes (the parts of the cell that make proteins) and prevents the bacteria from forming proteins. It inhibits protein synthesis, which stops bacteria from growing.
• Quinupristin: Quinupristin works in a similar way but targets a different part of the ribosome. When combined with dalfopristin, quinupristin enhances the effect of dalfopristin, making it more effective against bacteria.
• Bactericidal Effect: Together, dalfopristin and quinupristin kill the bacteria by preventing them from making the proteins they need to survive and reproduce. The combination is more powerful than either drug used alone.

This combination of two antibiotics is especially useful in treating certain infections that are resistant to other types of antibiotics.

Like all medications, dalfopristin and quinupristin can cause side effects. While many people tolerate the drug without serious issues, common side effects include:

• Pain or Redness at the Injection Site: Since the medication is given intravenously, some patients may experience irritation or pain at the site where the IV is inserted.
• Nausea or Vomiting: Some patients may feel nauseous or even vomit, especially during the first few days of treatment.
• Diarrhea: This is a common side effect of many antibiotics, including dalfopristin and quinupristin.
• Fever: A mild fever can develop in some people as a reaction to the medication.
• Muscle Pain or Joint Pain: Some patients report experiencing muscle or joint pain during treatment.

Serious side effects, although rare, can include:

• Allergic Reactions: Some patients may have allergic reactions, such as difficulty breathing, rash, or swelling of the face, lips, or throat. If you experience any of these symptoms, seek immediate medical attention.
• Liver Damage: Dalfopristin and quinupristin can cause liver issues, including jaundice (yellowing of the skin or eyes), dark urine, or pain in the upper right side of the abdomen. Your doctor will monitor liver function during treatment.

If you experience any severe side effects, such as difficulty breathing or signs of liver problems, contact your healthcare provider immediately.

Before taking dalfopristin and quinupristin, there are some important precautions to keep in mind:

• Allergic Reactions: Let your doctor know if you have a known allergy to any antibiotics, particularly other streptogramins or macrolides, as you may be at increased risk of an allergic reaction.
• Liver Disease: Dalfopristin and quinupristin can affect liver function, so patients with liver disease may require a lower dose or close monitoring during treatment.
• Pregnancy and Breastfeeding: The safety of dalfopristin and quinupristin during pregnancy or breastfeeding has not been well studied. If you are pregnant, planning to become pregnant, or breastfeeding, discuss the risks and benefits with your healthcare provider.
• Kidney Function: People with kidney issues may require a lower dose or may need to avoid this medication altogether, as it is processed by the liver and kidneys.

 Dalfopristin and quinupristin can interact with other medications, so it is important to inform your doctor about all the medications you are currently taking. Some key interactions include:

• Cytochrome P450 Enzyme Inhibitors: Dalfopristin and quinupristin can affect the activity of liver enzymes that process certain drugs. For example, taking this medication with clarithromycin or ketoconazole may increase the levels of other medications in your body.
• Other Antibiotics: Using this combination with other antibiotics, especially those used to treat serious infections like linezolid or vancomycin, may increase the risk of side effects.
• Medications Affecting the Liver: Since dalfopristin and quinupristin are processed by the liver, taking them with other drugs that affect liver function can change how these antibiotics work.

Always consult your doctor or pharmacist before taking other medications with dalfopristin and quinupristin to avoid potentially harmful interactions.

The recommended dosage of dalfopristin and quinupristin for adults is typically 7.5 mg/kg of body weight for each drug, given intravenously every 8 to 12 hours. The exact dosage and duration will depend on the infection being treated and the patient’s health status.

Always follow your healthcare provider’s instructions carefully to avoid complications or side effects.

Dalfopristin and quinupristin are available only by prescription. Your doctor will evaluate your condition and determine if this combination antibiotic is appropriate for you, based on the type of infection and your overall health.

If you have any questions or concerns about taking this medication, speak with your healthcare provider.

1. What are Dalfopristin and Quinupristin used for?
   They treat serious bacterial infections, especially those caused by multi-resistant gram-positive bacteria like MRSA and VRE.

2. Are Dalfopristin and Quinupristin used separately or together?
   They are used together as a fixed-dose combination called Synercid.

3. What class of antibiotics do Dalfopristin and Quinupristin belong to?
   They are streptogramin antibiotics.

4. How do these drugs work?
   They inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit.

5. Are Dalfopristin and Quinupristin bactericidal or bacteriostatic?
   The combination is primarily bactericidal against susceptible organisms.

6. What infections are treated with Dalfopristin/Quinupristin?
   Complicated skin and skin structure infections, bloodstream infections, and nosocomial pneumonia.

7. How are they administered?
   By intravenous infusion.

8. What is the usual dosing regimen?
   Typically 7.5 mg/kg every 8 to 12 hours, infused over 60 minutes.

9. What are common side effects?
   Infusion site pain, arthralgia, myalgia, nausea, and diarrhea.

10. Can Dalfopristin/Quinupristin cause liver problems?
    Yes, elevations in liver enzymes can occur.

11. Are dose adjustments needed in kidney impairment?
    No dose adjustment is typically required for renal impairment.

12. Are dose adjustments needed in liver impairment?
    Caution is advised; dose adjustment may be considered.

13. Do these antibiotics interact with other drugs?
    Yes, especially with CYP3A4 substrates; levels of other drugs like warfarin or cyclosporine can be affected.

14. Is Dalfopristin/Quinupristin safe during pregnancy?
    There is limited data; use only if clearly needed.

15. How long is the treatment duration?
    Depends on infection severity and clinical response, generally 7 to 14 days.

16. Are allergic reactions common?
    They can occur though rare.

17. Can these drugs cause muscle or joint pain?
    Yes, myalgia and arthralgia are noted side effects.

18. Is Dalfopristin/Quinupristin effective against gram-negative bacteria?
    No, they are mainly active against gram-positive bacteria.

19. Should liver function be monitored during therapy?
    Yes, regular monitoring is recommended.

20. How should the drug be stored?
    Refrigerated before reconstitution; protect from light.